DJ Incyte Corp. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Incyte Corp. $(INCY)$ slid 2.64% to $124.37 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.25% to 7,711.76 and Dow Jones Industrial Average falling 0.02% to 53,559.99.
This was the stock's third consecutive day of losses.
Incyte Corp. closed 6.21% short of its 52-week high of $132.60, which the company achieved on July 28th.
The stock underperformed when compared to some of its competitors Friday, as Alnylam Pharmaceuticals Inc. $(ALNY)$ rose 0.23% to $237.10, Bio-Techne Corp. (TECH) fell 0.17% to $72.35, and BioMarin Pharmaceutical Inc. $(BMRN)$ fell 0.96% to $64.67.
Trading volume (1.2 M) remained 550,007 below its 50-day average volume of 1.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.